Crossref
Plozasiran, an RNA interference agent targeting APOC3, for mixed hyperlipidemia
Yearbook of Paediatric Endocrinology · 30.09.2025
DOI: 10.1530/ey.22.12.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Ballantyne C.M..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
C.M., B. (2025). Plozasiran, an RNA interference agent targeting APOC3, for mixed hyperlipidemia. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.12.11
Vancouver
C.M. B. Plozasiran, an RNA interference agent targeting APOC3, for mixed hyperlipidemia. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.12.11
BibTeX
@article{CM2025,
author = {C.M., Ballantyne},
title = {Plozasiran, an RNA interference agent targeting APOC3, for mixed hyperlipidemia},
journal = {Yearbook of Paediatric Endocrinology},
year = {2025},
doi = {10.1530/ey.22.12.11}
}
EUVIMED